Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-05 @ 6:34 PM
Study NCT ID:
NCT02298192
Status:
COMPLETED
Last Update Posted:
2017-05-23
First Post:
2014-11-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Sponsor:
Novo Nordisk A/S
Organization:
Study Overview
Official Title:
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
Status:
COMPLETED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DUAL™ VI
Brief Summary:
This trial is conducted in Europe, North America and the United States of America.
The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.
The aim of this trial is to compare two different titration algorithms of insulin degludec/liraglutide.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: